Examples of using Apparent clearance in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
gabapentin does not appear to change the apparent clearance of lamotrigine.
than for adults(7.2 h) and apparent clearance was faster(1.5 ml/ min/ kg)
However, the apparent clearance was faster(1.30 versus 1.14 l/h/kg)
Based on the population pharmacokinetics analysis of data for 614 patients with a weight range of 26 to 145 kg, the bexarotene apparent clearance increases with increasing body weight.
based on population pharmacokinetic simulations, omalizumab serum elimination half-life at steady state averaged 24 days and apparent clearance at steady state for a patient of 80 kg weight was 3.0 ml/kg/day.
Based on population PK analysis using a two-compartment model, healthy subjects and MM patients had comparable apparent clearance(CL/F) and apparent central volume of distribution V2/F.
and a mean apparent clearance ranging from 7.5 to 11 L/hr.
In a study of subjects with Gilbert's Syndrome, mean apparent clearance was reduced by 32% compared with normal controls but the values are
The median apparent clearance of lamotrigine was 0.31, 0.24 or 0.10 mL/ min/
body weight was significantly correlated to apparent clearance(clearance increased with an increase in body weight)
Apparent clearance or clearance ml/kg/day.
Age does not affect the apparent clearance in heart failure patients.
The apparent clearance(CI/F) of canakinumab increases with body weight.
This appears to be due to reduction of apparent clearance in these patients.
Elimination of A771726 is slowand characterised by an apparent clearance of about 31 ml/hr.
Elimination of A771726 is slow and characterised by an apparent clearance of about 31 ml/hr.
No changes to lamivudine apparent clearance and volume of distribution,
In asthma patients the omalizumab serum elimination half-life averaged 26 days, with apparent clearance averaging 2.4± 1.1 ml/ kg/ day.
The pharmacokinetics of ribavirin is altered in patients with renal dysfunction due to reduction of apparent clearance in these patients.
Based on population pharmacokinetic analysis, no clinically significant relationship between predicted apparent clearance and patient age, bodyweight, gender and ethnicity were observed.
